Corcept Therapeutics Inc Cash Flow Statement

Cash Flow Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -20.17M-25.97M-32.35M8.14M129.12M75.41M94.18M106.01M112.51M101.42M106.14M141.21M
Share-based Compensation 1.81M2.12M3.44M5.31M5.20M5.20M6.01M7.06M13.36M23.75M29.31M33.54M42.93M42.44M48.94M61.35M
Deferred Taxes -76.70M14.07M16.88M14.09M4.35M-33.91M-29.49M-40.19M
Gains from Investment Securities 7.96M0.70M0.30M0.06M3.00M5.50M17.66M20.45M6.09M10.86M22.84M39.75M47.60M60.27M
Non-cash Items 8.48M10.47M263.13M
Cash from Operations -17.97M-22.29M-27.40M-36.02M-37.06M-27.38M3.13M18.39M60.94M115.67M136.12M151.97M167.89M120.32M127.04M198.07M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.68M4.41M3.68M2.85M1.93M0.50M1.47M1.71M-5.08M2.19M9.13M10.94M
Amortization of Deferred Charges 0.02M0.04M0.03M0.02M0.02M0.01M1.47M1.71M2.00M
Depreciation & Amortization (CF) 0.01M0.01M0.00M0.03M0.07M0.14M0.15M0.09M0.11M0.24M0.70M0.53M1.07M1.26M1.04M0.80M
Change in Working Capital
Change in Receivables 0.56M0.87M1.91M2.89M3.64M12.90M-12.90M2.34M6.27M1.43M3.43M10.07M12.85M
Change in Inventory 4.66M0.88M-0.25M-0.81M0.68M2.26M7.78M1.04M3.51M-3.44M-1.20M-1.26M-0.30M
Change in Account Payables -0.03M-0.45M2.79M0.19M-1.42M-0.49M-0.56M0.96M6.29M-0.39M-0.73M3.16M-3.60M4.76M5.78M-2.25M
Change in Accured Expenses -0.28M1.79M-1.46M0.28M2.44M-2.95M1.38M5.70M8.55M5.04M2.96M7.23M6.48M2.93M17.65M38.24M
Change in Taxes 0.24M0.15M0.01M0.01M8.69M1.21M3.78M
Other Working Capital Changes -0.72M-0.14M-0.28M0.48M0.29M0.53M-0.80M1.32M0.70M5.07M3.40M-1.69M4.01M6.56M11.60M-5.42M
Investing Activities
Capital Expenditures 0.03M0.15M0.13M0.17M0.02M0.19M0.42M0.30M1.09M1.24M0.47M0.41M0.14M2.17M
Change in Acquisitions & Divestments 3.59M29.95M142.66M182.29M302.09M398.94M241.15M419.79M412.88M
Cash from Investing Activities 3.59M-0.03M-0.15M-0.13M-0.17M-0.02M-0.19M-73.46M-90.77M-117.83M-119.26M136.13M-114.33M90.91M-177.60M
Financing Activities
Other financing activities -0.29M
Cash from Financing Activities 23.52M23.00M42.48M89.57M-0.97M-3.08M13.07M-7.10M-7.95M-14.34M-28.64M12.21M-302.59M-17.28M-148.72M-28.35M
Additional items
Change in Cash 9.15M0.71M15.06M53.40M-38.16M-30.63M16.19M11.10M-20.47M10.56M-10.36M44.92M1.43M-11.29M69.22M-7.89M
Beginning Cash Balance 14.72M23.87M-15.06M-53.40M38.16M30.63M-16.19M40.44M51.54M31.06M41.62M31.27M76.19M77.62M66.33M135.55M
Free Cash Flow -17.97M-22.29M-27.43M-36.17M-37.19M-27.55M3.11M18.20M60.52M115.37M135.03M150.73M167.42M119.91M126.90M195.90M
Net Cash Flow 9.15M0.71M15.06M53.40M-38.16M-30.63M16.19M11.10M-20.47M10.56M-10.36M44.92M1.43M-11.29M69.22M-7.89M